|
The complaint evaluation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and in-house testing for architect prolactin reagent lot 20320ui00.Trending review determined no adverse trend for the issue for the product.Return testing was not completed as returns were not available.In-house testing was performed with a retained kit of lot 20320ui00, which mimic patient samples, and all specifications were met and found that the lot is performing acceptably.Device history record review did not identify any non-conformances or deviations with the complaint lot and complaint issue.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Per product labeling for diagnostic purposes, results should be used in conjunction with other data; e.G., symptoms, results of other tests, clinical impressions, etc.If the prolactin results are inconsistent with clinical evidence, additional testing is suggested to confirm the result.Based on the investigation no product deficiency was identified for the architect prolactin reagent lot 20320ui00.
|